CYT
Cyteir Therapeutics Inc
$3.02
Earnings Summary
Revenue | $0Mn |
Net Profits | $-3.53Mn |
Net Profit Margins | -Inf% |
Highlights
Cyteir Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2023. On a quarterly growth basis, Cyteir Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.
Cyteir Therapeutics Inc’s net profit jumped 65.81% since last year same period to $-3.53Mn in the Q3 2023. On a quarterly growth basis, Cyteir Therapeutics Inc has generated 57.97% jump in its net profits since last 3-months.
Cyteir Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2023. On a quarterly growth basis, Cyteir Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Cyteir Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.25 |
EPS Estimate Current Year | -0.25 |
Highlights
Cyteir Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.25 - a 0% jump from last quarter’s estimates.
Cyteir Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.25.
Key Ratios
Key ratios of the Cyteir Therapeutics Inc post its Q1 2024 earnings
Earning Per Share (EPS) | 0 |
Highlights
Cyteir Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2024. This indicates that the Cyteir Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-02 | -0.25 | 0 | 100% |
₹0 US Stocks a/c Opening Fee